蔡锐刚,徐兵河.吉西他滨联合顺铂方案治疗晚期乳腺癌临床研究[J].中国肿瘤,2014,23(7):612-615. |
吉西他滨联合顺铂方案治疗晚期乳腺癌临床研究 |
Gemcitabine plus Cisplatin for the Treatment of Advanced Breast Cancer |
投稿时间:2014-01-06 |
DOI:10.11735/j.issn.1004-0242.2014.07.A016 |
|
 |
中文关键词: 乳腺癌 顺铂 吉西他滨 化学疗法 |
英文关键词:breast cancer cisplatin gemcitabine chemotherapy |
基金项目: |
|
摘要点击次数: 2105 |
全文下载次数: 1017 |
中文摘要: |
摘 要:[目的] 观察吉西他滨联合顺铂方案治疗晚期乳腺癌的近期疗效和毒副反应。[方法] 38例晚期乳腺癌患者给予GP方案化疗:吉西他滨1000mg/m2,d1、d8,顺铂30mg/m2,d1~d3,21d为1个周期。每2个周期评价疗效。[结果] 38例患者中位治疗周期数为6个周期(2~10个周期),获CR 3例(7.9%),PR 13例(34.2%),SD 10例(26.3%),PD 12例(31.6%),总有效率(CR+PR)为42.1%。主要毒副作用为骨髓抑制和胃肠道反应。Ⅲ度或Ⅲ度以上毒副反应为白细胞下降(36.84%)、中性粒细胞下降(36.84%)、血小板减少(15.79%)、呕吐(13.15%)和贫血(7.89%)。[结论] 吉西他滨联合顺铂治疗晚期乳腺癌近期疗效好,毒副反应可以耐受,可作为晚期乳腺癌的治疗选择。 |
英文摘要: |
Abstract:[Purpose] To evaluate the efficacy and toxicity of combined chemotherapy of gemcitabine and cisplatin for advanced breast cancer.[Methods] A total of 38 cases with advanced breast cancer received GP regimen, 21 days as a cycle,gemcitabine 1000mg/m2 on day 1,8,and DDP 30mg/m2 on day 1,3. The efficacy was evaluated every 2 cycles.[Results] Of 38 patients,the median treatment cycle was 6 cycles(2~10cycles). CR achieved in 3 cases (7.9%),PR,13(34.2%);SD,10 (26.3%) and PD,12(31.6%). The overall response rate was 42.1%.The main toxicities were hematologic toxicity and gastrointestinal toxicity. The toxicities ≥grade 3 were neutropenia (36.84%),leukopenia(36.84%),thrombocytopenia(15.79%),nausea/vomiting(13.15%) and anemia(7.89%).[Conclusion] Combination of gemcitabine plus cisplatin is an effective regimen and toxicity is tolerable regimen,as a treatment option for advanced breast cancer. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |